Data as of Dec 06
| +0.10 / +1.57%|
The 7 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 7.50. The median estimate represents a +24.03% increase from the last price of 6.45.
The current consensus among 7 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.